Unanimous FDA panel suggestions favor Nirsevimab approval, a game-changing antibody by AstraZeneca, to safeguard infants from RSV, elevating hopes for improved toddler healthcare.
Authentic Supply: https://www.parentherald.com/articles/110303/20230609/fda-panel-unanimously-recommends-approval-nirsevimab-protect-infants-rsv.htm
Written by: on 2023-06-09 06:43:26